4Q'25 vs. 4Q'24 Results Sales: € 1.058 Bn (+1.9% vs. -1.4% BS(e) and +1.0% consensus); EBITDA: € 881.0 M (+2.1% vs. +0.1% BS(e) and +1.0% consensus); FY2025 vs. FY2024 Results Sales: € 3.995 Bn (+1.4% vs. +0.5% BS(e) and +1.1% consensus); EBITDA: € 3.317 Bn (+2.1% vs. +1.5% BS(e) and +1.8% consensus); Net Profit: € -361.0 M (€ -28.0 M in FY2024);
INEOS Quattro: conference call comments|NIH: improvement in certain indicators in H2, but still little visibility on M&A|Ardagh Group surprises with strong increase in glass EBITDA in Q4|Clariane : Satisfactory 2025 results thanks to strong recovery in H2 25 and B2/B+ ratings assigned by Moody’s and S&P|
INEOS Quattro: conference call comments|NIH : amélioration de certains indicateurs au S2 mais toujours peu de visibilité sur le M&A|Ardagh Group surprend avec une forte hausse de l’EBITDA verre au T4|Clariane : Résultats 2025 satisfaisants grâce à un bon rattrapage au 2nd semestre et ratings B2/B+ attribués par Moody’s et S&P|
Rdos. 4T'25 vs 4T'24: Ventas: 1.058 M euros (+1,9% vs +1,4% BS(e) y +1,0% consenso); EBITDA: 881,0 M euros (+2,1% vs +0,1% BS(e) y +1,0% consenso). Rdos. 2025 vs 2024: Ventas: 3.995 M euros (+1,4% vs +1,2% BS(e) y +1,1% consenso); EBITDA: 3.317 M euros (+2,1% vs +1,5% BS(e) y +1,8% consenso); BDI: -361,0 M euros (-28,0 M euros en 2024).
NEWS SUMMARY: ACCIONA, ACCIONA ENERGÍA, ACERINOX, AMADEUS, CELLNEX, COLONIAL, ELECTRICITY SECTOR, FCC, GLOBAL DOMINION, GRIFOLS, IAG, MERLIN, OHLA, REDEIA, SACYR, SOLARIA, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Doubts continue to plague Nasdaq, but software rallies after harsh punishment European s...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, ACERINOX, AMADEUS, CELLNEX, COLONIAL, FCC, GLOBAL DOMINION, GRIFOLS, IAG, MERLIN, OHLA, REDEIA, S. ELÉCTRICO, SACYR, SOLARIA, VISCOFAN. EUROPA:.n/a. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Siguen las dudas en e...
4Q'25 vs. 4Q'24 Results Sales: € 13.095 Bn (+9.8% vs. +10.7% BS(e) and +11.1% consensus); EBITDA: € 853.0 M (+9.8% vs. +6.9% BS(e) and +11.6% consensus); EBIT: € 603.0 M (+18.0% vs. +17.8% BS(e) and +6.7% consensus); Net Profit: € 295.0 M (+32.3% vs. +14.3% BS(e) and +20.1% consensus); FY2025 vs. FY2024 Results Sales: € 49.848 Bn (+19.7% vs. +20.0% BS(e) and +20.1% consensus); EBITDA: € 3.07 Bn (+25.0% vs. +24.1% BS(e) and +25.6% consensus); EBIT: € 2.1 Bn (+32.1% vs. +32.0% BS(e) and +28.4% con...
4Q'25 vs. 4Q'24 Results Sales: € 2.715 Bn (+8.4% vs. +7.3% BS(e) and +0.2% consensus); EBITDA: € 426.0 M (+27.5% vs. +12.8% BS(e) and +12.0% consensus); EBIT: € 276.0 M (+305.9% vs. +293.9% BS(e) and +293.1% consensus); FY2025 vs. FY2024 Results Sales: € 9.627 Bn (+5.2% vs. +4.9% BS(e) and +3.0% consensus); EBITDA: € 1.457 Bn (+8.6% vs. +4.9% BS(e) and +4.7% consensus); EBIT: € 967.0 M (+7.3% vs. +6.4% BS(e) and +6.4% consensus);
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.